Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Barcellini, W ^a   Fattizzo, B ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; FERRITIN; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; BIOLOGICAL MARKER;

AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CELL COUNT; BLOOD SMEAR; COOMBS TEST; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HEART VALVE PROSTHESIS; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPERBILIRUBINEMIA; HYPERFERRITINEMIA; INTRAVASCULAR HEMOLYSIS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; RETICULOCYTE; RETICULOCYTOPENIA; REVIEW; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; ANEMIA, HEMOLYTIC, AUTOIMMUNE; BLOOD; ERYTHROCYTE COUNT; PATHOLOGY;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; ERYTHROCYTE COUNT; HEMOLYSIS; HUMANS;

EID: 84956931124     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/635670     Document Type: Review

References (31)

1. L. D. Petz and G. Garratty, Immune Hemolytic Anemias, Churchill Livingstone, Philadelphia, Pa, USA, 2nd edition, 2004.
2. W. Barcellini, B. Fattizzo, A. Zaninoni et al., "Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: aGIMEMAstudy of 308 patients, " Blood, vol. 124, no. 19, pp. 2930-2936, 2014.
3. B. Fattizzo, A. Zaninoni, F. Nesa et al., "Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias, " American Journal of Hematology, vol. 90, no. 8, pp. E149-E151, 2015.
4. P. A. Arndt, R. M. Leger, and G. Garratty, "Serologic findings in autoimmune hemolytic anemia associated with immunoglobulinMwarmautoantibodies, " Transfusion, vol. 49, no. 2, pp. 235-242, 2009.
5. World Health Organization, Preventing and Controlling Anaemia through Primary Health Care: A Guide for Health Administrators and Programme Managers, World Health Organization, 1989, http://www. who. int/nutrition/publications/micronutrients/ anaemia iron deficiency/9241542497. pdf.
6. M. Michel, V. Chanet, A. Dechartres et al., "The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases, " Blood, vol. 114, no. 15, pp. 3167-3172, 2009.
7. N. Aladjidi, G. Leverger, T. Leblanc et al., "New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children, " Haematologica, vol. 96, no. 5, pp. 655-663, 2011.
8. J. L. Liesveld, J. M. Rowe, and M. A. Lichtman, "Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases, " Blood, vol. 69, no. 3, pp. 820-826, 1987.
9. R. Russo, A. Gambale, C. Langella, I. Andolfo, S. Unal, and A. Iolascon, "Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores, " American Journal of Hematology, vol. 89, no. 10, pp. E169-E175, 2014.
10. O. Arbach, R. Funck, F. Seibt, and A. Salama, "Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia, " TransfusionMedicine andHemotherapy, vol. 39, no. 3, pp. 221-223, 2012.
11. M. Mariani, W. Barcellini, C. Vercellati et al., "Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect, " Haematologica, vol. 93, no. 9, pp. 1310-1317, 2008.
12. A. Zanella, E. Fermo, P. Bianchi, and G. Valentini, "Red cell pyruvate kinase deficiency: molecular and clinical aspects, " British Journal of Haematology, vol. 130, no. 1, pp. 11-25, 2005.
13. R. A. Brodsky, "Paroxysmal nocturnal hemoglobinuria, " Blood, vol. 124, no. 18, pp. 2804-2811, 2014.
14. G. Mecozzi, A. D. Milano, M. De Carlo et al., "Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study, " Journal of Thoracic and Cardiovascular Surgery, vol. 123, no. 3, pp. 550-556, 2002.
15. O. Pourrat, R. Coudroy, and F. Pierre, "Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators, " European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 189, pp. 68-72, 2015.
16. M. Scully, B. J. Hunt, S. Benjamin et al., "Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies, " British Journal of Haematology, vol. 158, pp. 323-335, 2012.
17. R. P. de Latour, J. Y. Mary, C. Salanoubat et al., "Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories, " Blood, vol. 112, no. 8, pp. 3099-3106, 2008.
18. C. Kaiser, U. Gembruch, V. Janzen, and A.-S. Gast, "Thrombotic thrombocytopenic purpura, " Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 10, pp. 2138-2140, 2012.
19. B. H. Bowman and A. Kurosky, "Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation, " Advances in Human Genetics, vol. 12, pp. 189-453, 1982.
20. M. Kristiansen, J. H. Graversen, C. Jacobsen et al., "Identification of the haemoglobin scavenger receptor, " Nature, vol. 409, no. 6817, pp. 198-201, 2001.
21. K. Ratanasopa, S. Chakane, M. Ilyas, C. Nantasenamat, and L. Bulow, "Trapping of human hemoglobin by haptoglobin: molecular mechanisms and clinical applications, " Antioxidants & Redox Signaling, vol. 18, no. 17, pp. 2364-2374, 2013.
22. A. W. Y. Shih, A. Mcfarlane, and M. Verhovsek, "Haptoglobin testing in hemolysis: measurement and interpretation, " American Journal of Hematology, vol. 89, no. 4, pp. 443-447, 2014.
23. G. F. Körmöczi, M. D. Säemann, C. Buchta et al., "Influence of clinical factors on the haemolysis marker haptoglobin, " European Journal of Clinical Investigation, vol. 36, no. 3, pp. 202-209, 2006.
24. A. Marchand, R. S. Galen, and F. Van Lente, "The predictive value of serum haptoglobin in hemolytic disease, " Journal of the American Medical Association, vol. 243, no. 19, pp. 1909-1911, 1980.
25. N. I. Berlin and P. D. Berk, "Quantitative aspects of bilirubin metabolism for hematologists, " Blood, vol. 57, no. 6, pp. 983-999, 1981.
26. P. D. Berk, J. R. Bloomer, R. B. Howe, and N. I. Berlin, "Constitutional hepatic dysfunction (Gilberts syndrome). A new definition based on kinetic studies with unconjugated radiobilirubin, " The American Journal of Medicine, vol. 49, no. 3, pp. 296-305, 1970.
27. K. Lechner and U. Jäger, "How I treat autoimmune hemolytic anemias in adults, " Blood, vol. 116, no. 11, pp. 1831-1838, 2010.
28. W. Barcellini and A. Zanella, "Rituximab therapy for autoimmune haematological diseases, " European Journal of Internal Medicine, vol. 22, no. 3, pp. 220-229, 2011.
29. S. Berentsen, "How I manage cold agglutinin disease, " British Journal of Haematology, vol. 153, no. 3, pp. 309-317, 2011.
30. S. Berentsen and G. E. TjØnnfjord, "Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia, " Blood Reviews, vol. 26, no. 3, pp. 107-115, 2012.
31. W. Barcellini, "Current treatment strategies in autoimmune hemolytic disorders, " Expert Review of Hematology, vol. 8, no. 5, pp. 681-691, 2015.